What influenced people with chronic or refractory breathlessness and advanced disease to take part and remain in a drug trial? A qualitative study
Abstract Background Recruitment and retention in clinical trials remains an important challenge, particularly in the context of advanced disease. It is important to understand what affects retention to improve trial quality, minimise attrition and reduce missing data. We conducted a qualitative stud...
Main Authors: | N. Lovell, S. N. Etkind, S. Bajwah, M. Maddocks, I. J. Higginson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-020-4129-2 |
Similar Items
-
Holistic services for people with advanced disease and chronic or refractory breathlessness: a mixed-methods evidence synthesis
by: Matthew Maddocks, et al.
Published: (2019-06-01) -
Episodic Breathlessness with and without Background Dyspnea in Advanced Cancer Patients Admitted to an Acute Supportive Care Unit
by: Sebastiano Mercadante, et al.
Published: (2020-07-01) -
Chapter 10 Breathlessness From Bodily Symptom to Existential Experience
Published: (2018) -
An optimised patient information sheet did not significantly increase recruitment or retention in a falls prevention study: an embedded randomised recruitment trial
by: Sarah Cockayne, et al.
Published: (2017-03-01) -
Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo‐controlled trial
by: Miriam J. Johnson, et al.
Published: (2019-12-01)